Accès direct au contenu


Version française > Publications

Publications 2016

MORGAND M, BOUVIN-PLEY M, PLANTIER JC, MOREAU A, ALESSANDRI E, SIMON F, PACE CS, PANCERA M, HO DD, POIGNARD P, BJORKMAN PJ, MOUQUET H, NUSSENZWEIG MC, KWONG PD, BATY D, CHAMES P, BRAIBANT M, BARIN F. A v1v2 neutralizing epitope is conserved in divergent non-m groups of hiv-1. J Acquir Immune Defic Syndr, 2016, 71, 237-245.

PREL A, CAVAL V, GAYON R, RAVASSARD P, DUTHOIT C, PAYEN E, MAOUCHE-CHRETIEN L, CRENEGUY A, NGUYEN TH, MARTIN N, PIVER E, SEVRAIN R, LAMOUROUX L, LEBOULCH P, DESCHASEAUX F, BOUILLE P, SENSEBE L, PAGES JC. Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles. Mol Ther Methods Clin Dev 2015, 2,e15039.

BEAUMONT E, ROCH E, CHOPIN L, ROINGEARD P. Hepatitis C virus E1 and E2 proteins used as separate immunogens induce neutralizing antibodies with additive properties. PLoS One 2016, 11, e0151626.

ROINGEARD P. Is hepatitis C virus eradication a realistic objective in the absence of a prophylactic vaccine ? Liver Int 2016, 36, 1076.

SILBERSTEIN E, ULITZKY L, ALVES LIMA L, CEHAN N, TEXEIRA CARVALHO A, ROINGEARD P, TAYLOR DR. HCV-mediated apoptosis of hepatocytes in culture and viral pathogenesis. PLoS One 2016 ; 11 : e0155708

GASSER R, HAMOUDI M, PELLICCIOTTA M, ZHOU Z, VISDELOUP C, COLLIN P, BRAIBANT M, LAGANE B, NEGRONI M. Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions. Retrovirology 2016, 13, 50.

ROINGEARD P, DRENEAU J, MEUNIER JC. Unravelling the multiple roles of apolipoprotein E in the hepatitis C virus lifecycle. Gut 2016, in press.

PIVER E, BOYER A, GAILLARD J, BULL A, BEAUMONT E, ROINGEARD P, MEUNIER JC. Ultrastructural organization of hepatitis C virus from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture. Gut 2016, in press.

KERVIEL A, DASH S, MONCORGE O, PANTHU B, PRCHAL J, DECIMO D, OHLMANN T, LINA B, FAVARD C, DECROLY E, OTTMAN M, ROINGEARD P, MURIAUX D. Involvment of an arginine triplet in M1 matrix protein interaction with membrane and in M1 recruitment into virus-like particles of the influenza A(HIN1)pdm09 virus. PLoS One 2016 ;11 :e0165421.

STEFIC K, SALMONA M, CAPITAO M, SPLITTGERBER M, MAAKAROUN-VERMESSE Z, NERE ML, BERNARD L, CHAIX ML, BARIN F, DELAUGERRE C. Unraveling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1 infected child using ultra-deep sequencing. J Antimicrob Chemother 2016, in press.

BRAND D, CAPSEC J, CHAILLON A, CAZEIN F, LE VU S, MOREAU A, PILLONEL J, BRUNET S, THIERRY D, GUILLON-GRAMMATICO L, LOT F, BARIN F. HIV surveillance combining an assay for identification of very recent infections and phylogenetic analyses on dried spots. AIDS 2016, in press.

ROINGEARD P, MELO CR. Lipid droplet hijacking by intracellular pathogens. Cell Microbiol 2016, in press.




  • Facebook
  • twitter
  • google
  • imprimer
  • version PDF
  • Envoyer cette page

English version 


Contact 


Inserm - U966 MAVIVH
10 boulevard Tonnellé - BP 3223
37032 Tours Cedex 1 - France
Tél. : 33 (2) 47 36 61 27
Fax : 33 (2) 47 36 61 26

Secrétariat :
E-mail : angelique.masse@univ-tours.fr

Directeur : Philippe ROINGEARD

E-mail : roingeard@med.univ-tours.fr

Directeur adjoint : Francis BARIN

E-mail : fbarin@med.univ-tours.fr

 

Retour au site institutionnel